Publications:

Prevalence and Characteristics of Cystic Fibrosis in Omani Children: A Multi-center Cross-sectional Study.

Oman Medical Journal

Al Oraimi, Sumaya S; Al Shidhani, Khoula K; Al Harthi, Hasina H; Al Sinani, Suaad S; Al Busaidi, Nasser N; Al Bimani, Muna M; Al Salmi, Qasem Q; Al Kindi, Hussein H

Publication Date: 2022-11

Variant appearance in text: CFTR: 1175T>G; Val392Gly

PubMed Link: 36458240

Variant Present in the following documents:

• Main text
• OMJ-37-06-2200006.pdf

View BVdb publication page

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study.

The Lancet. Respiratory Medicine

Rosenfeld, Margaret M; Wainwright, Claire E CE; Higgins, Mark M; Wang, Linda T LT; McKee, Charlotte C; Campbell, Daniel D; Tian, Simon S; Schneider, Jennifer J; Cunningham, Steve S; Davies, Jane C JC; ,

Publication Date: 2018-07

Variant appearance in text: CFTR: V392G

PubMed Link: 29886024

Variant Present in the following documents:

• Main text

View BVdb publication page

Defining a mutational panel and predicting the prevalence of cystic fibrosis in oman.

Sultan Qaboos University Medical Journal

Fass, Uwe W UW; Al-Salmani, Majid M; Bendahhou, Said S; Shivalingam, Ganji G; Norrish, Catherine C; Hebal, Kallesh K; Clark, Fiona F; Heming, Thomas T; Al-Khusaiby, Saleh S

Publication Date: 2014-08

Variant appearance in text: CFTR: 1175T>G; Val392Gly

PubMed Link: 25097766

Variant Present in the following documents:

• Main text

View BVdb publication page